Ali Keshavarzian to Antiparkinson Agents
This is a "connection" page, showing publications Ali Keshavarzian has written about Antiparkinson Agents.
Connection Strength
0.339
-
Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol. 2020 10 20; 18(1):137.
Score: 0.180
-
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun. 2019 01 18; 10(1):310.
Score: 0.159